| 000 | 01471 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512015557.0 | ||
| 264 | 0 | _c19890911 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1989.tb03465.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPersson, L I | |
| 245 | 0 | 0 |
_aChanges in CSF and brain soluble proteins following vigabatrin treatment in rats. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _c1989 |
||
| 300 |
_a73S-77S p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAminocaproates _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 |
_aCerebrospinal Fluid Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Two-Dimensional |
| 650 | 0 | 4 | _aIsoelectric Focusing |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 | _aVigabatrin |
| 700 | 1 | _aRönnbäck, L | |
| 700 | 1 | _aBen-Menachem, E | |
| 700 | 1 | _aEriksson, P | |
| 700 | 1 | _aNilsson, M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 27 Suppl 1 _gp. 73S-77S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1989.tb03465.x _zAvailable from publisher's website |
| 999 |
_c2763780 _d2763780 |
||